- Home
- ESEA vs OVID Comparison
ESEA vs OVID Comparison
Compare ESEA & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESEA | OVID |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 557.0M | 562.5M |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ESEA | OVID |
|---|---|---|
| Price | $66.20 | $2.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $90.00 | $6.00 |
| AVG Volume (30 Days) | 27.8K | ★ 1.7M |
| Earning Date | 11-17-2026 | 11-11-2026 |
| Dividend Yield | ★ 4.74% | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,252,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.12 | N/A |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $51.00 | $1.18 |
| 52 Week High | $79.67 | $3.11 |
Technical Indicators
Market Signals| Indicator | ESEA | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 31.79 | 34.58 |
| Support Level | $63.47 | $1.95 |
| Resistance Level | $73.39 | $2.79 |
| Average True Range (ATR) | 2.07 | 0.13 |
| MACD | -0.47 | -0.02 |
| Stochastic Oscillator | 2.10 | 16.84 |
Price Performance
Historical ComparisonAbout ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.